Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
收盘时
US$282.6
+US$5.27 · +1.90%
盘中时间采用ET。市场数据可能有所延迟。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日内区间
当前US$282.6
52周区间
当前US$282.6
盘中时间采用ET。市场数据可能有所延迟。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日内区间
当前US$282.6
52周区间
当前US$282.6
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 251.16亿 USD | 225.95亿 USD | 204.98亿 USD | 184.49亿 USD | 171.08亿 USD |
| 销货成本 | 90.51亿 USD | 80.5亿 USD | 80.04亿 USD | 74.09亿 USD | 63.99亿 USD |
| 毛利 | 160.65亿 USD | 145.45亿 USD | 124.94亿 USD | 110.4亿 USD | 107.09亿 USD |
| 研究与开发 | 15.82亿 USD | 14.66亿 USD | 12.93亿 USD | 12.3亿 USD | 11.33亿 USD |
| 销售、一般及管理费用 | 86.51亿 USD | 75.03亿 USD | 69.2亿 USD | 60.76亿 USD | 58.13亿 USD |
| 营业费用 | 111.76亿 USD | 108.56亿 USD | 82.13亿 USD | 73.06亿 USD | 69.46亿 USD |
| 利息收入 | 1.21亿 USD | 1.39亿 USD | 7500万 USD | 9400万 USD | 6800万 USD |
| 利息支出 | 6.07亿 USD | 3.96亿 USD | 3.56亿 USD | 3.37亿 USD | 3.37亿 USD |
| 折旧和摊销 | 11.93亿 USD | 10.5亿 USD | 10.28亿 USD | 9.98亿 USD | 9.9亿 USD |
| 营业利润 | 48.89亿 USD | 36.89亿 USD | 42.81亿 USD | 37.34亿 USD | 37.63亿 USD |
| 净利润 | 32.46亿 USD | 29.93亿 USD | 31.65亿 USD | 23.58亿 USD | 19.94亿 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化,并非 GoAI 建议。
年度分割调整后的每股现金分配。
US$3.40
2025年(完整年度)+31.5% 自从 2021
2026年(部分年度):US$2.64
US$2.585
2,021
US$2.835
2,022
US$3.05
2,023
US$3.24
2,024
US$3.40
2,025
US$2.64
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月30日 | US$0.88Quarterly | 2026年9月30日 | 2026年10月30日 |
股息 | 2026年6月30日 | US$0.88Quarterly | 2026年6月30日 | 2026年7月31日 |
股息 | 2026年3月31日 | US$0.88Quarterly | 2026年3月31日 | 2026年4月30日 |
股息 | 2025年12月31日 | US$0.88Quarterly | 2025年12月31日 | 2026年1月30日 |
股息 | 2025年9月30日 | US$0.84Quarterly | 2025年9月30日 | 2025年10月31日 |
股息 | 2025年6月30日 | US$0.84Quarterly | 2025年6月30日 | 2025年7月31日 |
除息 2026年9月30日
US$0.88
Quarterly
2026年9月30日登记 · 支付日 2026年10月30日
除息 2026年6月30日
US$0.88
Quarterly
2026年6月30日登记 · 支付日 2026年7月31日
除息 2026年3月31日
US$0.88
Quarterly
2026年3月31日登记 · 支付日 2026年4月30日
除息 2025年12月31日
US$0.88
Quarterly
2025年12月31日登记 · 支付日 2026年1月30日
除息 2025年9月30日
US$0.84
Quarterly
2025年9月30日登记 · 支付日 2025年10月31日
除息 2025年6月30日
US$0.84
Quarterly
2025年6月30日登记 · 支付日 2025年7月31日
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T1864.52亿0.14%129.43万亿 JPY0.09%JP¥122,8500.00%
Vanguard Morningstar Total Stock Market ETFVTI35.51亿0.15%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO29.68亿0.17%1.8万亿 USD0.03%US$715.13-0.06%
iShares Core S&P 500 ETFIVV12.87亿0.14%8964.4亿 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY11.75亿0.14%8172亿 USD0.09%US$778.1-0.06%
State Street Health Care Select Sector SPDR ETFXLV6.79亿1.56%443.1亿 USD0.08%US$171.99+0.69%
Vanguard Morningstar Growth ETFVUG6.47亿0.17%3846亿 USD0.03%US$91.64-0.36%
Vanguard Dividend Appreciation ETFVIG6.32亿0.48%1324亿 USD0.04%US$240.04+0.41%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Morningstar Growth ETFVUG
Vanguard Dividend Appreciation ETFVIGAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。